ALDX

Aldeyra Therapeutics (ALDX)

About Aldeyra Therapeutics (ALDX)

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Details

Daily high

$5.02

Daily low

$4.79

Price at open

$4.81

52 Week High

$6.55

52 Week Low

$2.71

Market cap

290.6M

Dividend yield

0.00%

Volume

430,457

Avg. volume

412,744

P/E ratio

-6.47

Aldeyra Therapeutics News